AstraZeneca has discontinued production of the Pulmicort (budesonide) CFC-free pressurised metered-dose inhaler and the NebuChamber spacer owing to manufacturing difficulties relating to technical aspects of the inhaler.
Patients can continue using Pulmicort inhaler until their supply is finished. They will then need to be transferred to an appropriate alternative such as Pulmicort Turbohaler, Easyhaler Budesonide or Budelin Novolizer.
Healthcare professionals should note that these products may require different inhalation techniques to Pulmicort. Patients may need to be advised and assessed on correct usage. Some preparations contain lactose and therefore should not be used in patients who are lactose intolerant.
Further information: AstraZeneca